You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Early parasite clearance following artemisinin-based combination therapy among Ugandan children with uncomplicated Plasmodium falciparum malaria
|
|---|---|
| Published in |
Malaria Journal, January 2014
|
| DOI | 10.1186/1475-2875-13-32 |
| Pubmed ID | |
| Authors |
Mary K Muhindo, Abel Kakuru, Prasanna Jagannathan, Ambrose Talisuna, Emmanuel Osilo, Francis Orukan, Emmanuel Arinaitwe, Jordan W Tappero, Frank Kaharuza, Moses R Kamya, Grant Dorsey |
| Abstract |
Artemisinin-based combination therapy (ACT) is widely recommended as first-line therapy for uncomplicated Plasmodium falciparum malaria worldwide. Artemisinin resistance has now been reported in Southeast Asia with a clinical phenotype manifested by slow parasite clearance. Although there are no reliable reports of artemisinin resistance in Africa, there is a need to better understand the dynamics of parasite clearance in African children treated with ACT in order to better detect the emergence of artemisinin resistance. |
Mendeley readers
The data shown below were compiled from readership statistics for 139 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 1% |
| United Kingdom | 2 | 1% |
| Tanzania, United Republic of | 1 | <1% |
| India | 1 | <1% |
| Switzerland | 1 | <1% |
| Unknown | 132 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 24 | 17% |
| Researcher | 20 | 14% |
| Student > Ph. D. Student | 19 | 14% |
| Student > Postgraduate | 11 | 8% |
| Student > Bachelor | 9 | 6% |
| Other | 28 | 20% |
| Unknown | 28 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 42 | 30% |
| Agricultural and Biological Sciences | 18 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 6% |
| Biochemistry, Genetics and Molecular Biology | 8 | 6% |
| Social Sciences | 7 | 5% |
| Other | 21 | 15% |
| Unknown | 34 | 24% |